�Research and Markets has announced the addition of the "The Top 10 World's Leading Pharmaceutical Companies: Pfizer" report to their offering.
In a extremely dynamic and fragmented pharmaceutical market, besieged by intense competition, rapid pace of technological innovations and the uncertainty regarding future political science regulations, the ability to anticipate modern competitive product introductions and marketing strategies is particularly important... and spells the difference 'tween success and failure. The TOP 10, a unique series of market intelligence service studies first introduced in 1987, is designed to provide the pharmaceutical industry executives, as well as companies planning to radiate into the pharmaceutical line of business, with strategically significant challenger information, analysis and sixth sense, critical to the development and execution of effective marketing and R&D programs. The study's major objectives include: to establish a comprehensive, factual, annually-updated and cost-effective; information base on performance, capabilities, goals and strategies of the world's leading pharmaceutical companies; to help electric current suppliers realistically assess their financial, selling and technological capabilities vis-�-vis leading competitors; to assist potential grocery store entrants in evaluating prospective acquisitions and joint venture candidates; and to full complement organizations' internal competitor data gathering efforts by providing strategic depth psychology, data reading and insight.
The study provides an approximately 50-page worldwide strategic overview of the pharmaceutic market, including sales calculate for major product segments (ethical, OTC, generics); key geographic regions (North America, Western Europe, Japan, Eastern Europe, and Latin America); major dose categories, including cardiovascular, gI, antibiotics, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatologic, oncological, and others. In addition, the report reviews major U.S. and international regulatory, technical, economic, demographic, and social trends with potentially significant impact on the pharmaceutical industry during the future five years, including word of such key issues as pricing, industry consolidation, market globalisation, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies.
The report provides: Executive Summary; Business Organization; Senior Management; Facilities and Employees; Technological Know-How; Product Portfolio Analysis; Marketing Tactics; Financial Analysis; R&D Expenditures and Major Programs; Collaborative Arrangements; and Strategic Direction.
Key Topics Covered
Section I: Executive Summary
Section II: Business Organization
Section III: Senior Management
Section IV: Facilities And Employees
Section V:Technological Know-How
Section VI: Product Portfolio Analysis
Section VII: Marketing Tactics
Section VIII: Financial Analysis
Section IX: R&D Expenditures And Major Programs
Section X: Collaborative Arrangements
Section XI: Strategic Direction
For more information visit here.
Research and Markets
More information
Saturday 6 September 2008
Subscribe to:
Posts (Atom)